Sun Pharmaceutical receives 9 ANDA approvals from USFDA in Q1FY14

16 Sep 2013 Evaluate

Sun Pharmaceutical Industries has filed four products for Abbreviated New Drug Applications and received nine approvals from the USFDA in the first quarter this fiscal. The company has now 320 ANDAs approval out of a total of 453 products filed with USFDA, and ANDAs approvals for remaining 133 products are still awaited. On a consolidated basis, the company now has 791 patent filings with 503 granted patents.

Sun Pharmaceutical Industries is an international, integrated, specialty pharmaceutical company. It manufactures and markets a large basket of pharmaceutical formulations as branded generics as well as generics in India, US and several other markets across the world.

Sun Pharma Inds. Share Price

1804.95 -13.65 (-0.75%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×